nodes	percent_of_prediction	percent_of_DWPC	metapath
Conivaptan—CYP3A4—Thiotepa—sarcoma	0.24	0.458	CbGbCtD
Conivaptan—CYP3A4—Mitoxantrone—sarcoma	0.103	0.197	CbGbCtD
Conivaptan—CYP3A4—Vincristine—sarcoma	0.071	0.136	CbGbCtD
Conivaptan—CYP3A4—Etoposide—sarcoma	0.065	0.124	CbGbCtD
Conivaptan—CYP3A4—Doxorubicin—sarcoma	0.0444	0.0848	CbGbCtD
Conivaptan—Electrocardiogram ST segment depression—Epirubicin—sarcoma	0.0121	0.0254	CcSEcCtD
Conivaptan—Electrocardiogram ST segment depression—Doxorubicin—sarcoma	0.0112	0.0235	CcSEcCtD
Conivaptan—Sepsis—Thiotepa—sarcoma	0.00593	0.0124	CcSEcCtD
Conivaptan—Sepsis—Dactinomycin—sarcoma	0.00589	0.0124	CcSEcCtD
Conivaptan—Phlebitis—Dactinomycin—sarcoma	0.00572	0.012	CcSEcCtD
Conivaptan—Urine output increased—Vincristine—sarcoma	0.00548	0.0115	CcSEcCtD
Conivaptan—Sepsis—Mitoxantrone—sarcoma	0.00513	0.0107	CcSEcCtD
Conivaptan—Cardiac failure—Thiotepa—sarcoma	0.00509	0.0107	CcSEcCtD
Conivaptan—Polyuria—Vincristine—sarcoma	0.00501	0.0105	CcSEcCtD
Conivaptan—Phlebitis—Mitoxantrone—sarcoma	0.00498	0.0104	CcSEcCtD
Conivaptan—Candida infection—Etoposide—sarcoma	0.00469	0.00984	CcSEcCtD
Conivaptan—Dehydration—Thiotepa—sarcoma	0.00462	0.00968	CcSEcCtD
Conivaptan—Hyponatraemia—Vincristine—sarcoma	0.00442	0.00927	CcSEcCtD
Conivaptan—Cardiac failure—Mitoxantrone—sarcoma	0.00439	0.00921	CcSEcCtD
Conivaptan—Oral candidiasis—Epirubicin—sarcoma	0.00433	0.00909	CcSEcCtD
Conivaptan—Hypomagnesaemia—Epirubicin—sarcoma	0.00433	0.00909	CcSEcCtD
Conivaptan—Hyponatraemia—Mitoxantrone—sarcoma	0.0043	0.00903	CcSEcCtD
Conivaptan—Sepsis—Etoposide—sarcoma	0.00426	0.00894	CcSEcCtD
Conivaptan—Phlebitis—Etoposide—sarcoma	0.00414	0.00868	CcSEcCtD
Conivaptan—Dehydration—Vincristine—sarcoma	0.00409	0.00859	CcSEcCtD
Conivaptan—Oral candidiasis—Doxorubicin—sarcoma	0.00401	0.00841	CcSEcCtD
Conivaptan—Hypomagnesaemia—Doxorubicin—sarcoma	0.00401	0.00841	CcSEcCtD
Conivaptan—Dehydration—Mitoxantrone—sarcoma	0.00399	0.00836	CcSEcCtD
Conivaptan—Hypokalaemia—Mitoxantrone—sarcoma	0.0039	0.00818	CcSEcCtD
Conivaptan—Hyperglycaemia—Thiotepa—sarcoma	0.00387	0.00812	CcSEcCtD
Conivaptan—Pneumonia—Thiotepa—sarcoma	0.00385	0.00807	CcSEcCtD
Conivaptan—Infestation NOS—Thiotepa—sarcoma	0.00383	0.00802	CcSEcCtD
Conivaptan—Infestation—Thiotepa—sarcoma	0.00383	0.00802	CcSEcCtD
Conivaptan—Pneumonia—Dactinomycin—sarcoma	0.00382	0.00801	CcSEcCtD
Conivaptan—Cardiac failure—Etoposide—sarcoma	0.00365	0.00766	CcSEcCtD
Conivaptan—Haematuria—Thiotepa—sarcoma	0.00365	0.00765	CcSEcCtD
Conivaptan—Pneumonia—Vincristine—sarcoma	0.00341	0.00716	CcSEcCtD
Conivaptan—Urinary tract disorder—Thiotepa—sarcoma	0.00339	0.00711	CcSEcCtD
Conivaptan—Urethral disorder—Thiotepa—sarcoma	0.00337	0.00706	CcSEcCtD
Conivaptan—Hyperglycaemia—Mitoxantrone—sarcoma	0.00334	0.00701	CcSEcCtD
Conivaptan—Pneumonia—Mitoxantrone—sarcoma	0.00332	0.00697	CcSEcCtD
Conivaptan—Urinary tract infection—Mitoxantrone—sarcoma	0.00321	0.00673	CcSEcCtD
Conivaptan—Cardiac disorder—Thiotepa—sarcoma	0.00319	0.00668	CcSEcCtD
Conivaptan—Haematuria—Mitoxantrone—sarcoma	0.00315	0.00661	CcSEcCtD
Conivaptan—Angiopathy—Thiotepa—sarcoma	0.00312	0.00653	CcSEcCtD
Conivaptan—Mediastinal disorder—Thiotepa—sarcoma	0.0031	0.00649	CcSEcCtD
Conivaptan—Mental disorder—Thiotepa—sarcoma	0.00301	0.00631	CcSEcCtD
Conivaptan—Urinary tract disorder—Vincristine—sarcoma	0.00301	0.00631	CcSEcCtD
Conivaptan—Erythema—Thiotepa—sarcoma	0.00299	0.00627	CcSEcCtD
Conivaptan—Malnutrition—Thiotepa—sarcoma	0.00299	0.00627	CcSEcCtD
Conivaptan—Urethral disorder—Vincristine—sarcoma	0.00299	0.00626	CcSEcCtD
Conivaptan—Erythema—Dactinomycin—sarcoma	0.00297	0.00622	CcSEcCtD
Conivaptan—Cardiac disorder—Vincristine—sarcoma	0.00283	0.00593	CcSEcCtD
Conivaptan—Pneumonia—Etoposide—sarcoma	0.00276	0.0058	CcSEcCtD
Conivaptan—Anaemia—Thiotepa—sarcoma	0.00276	0.00579	CcSEcCtD
Conivaptan—Angiopathy—Vincristine—sarcoma	0.00276	0.00579	CcSEcCtD
Conivaptan—Infestation NOS—Etoposide—sarcoma	0.00275	0.00576	CcSEcCtD
Conivaptan—Infestation—Etoposide—sarcoma	0.00275	0.00576	CcSEcCtD
Conivaptan—Mediastinal disorder—Vincristine—sarcoma	0.00274	0.00576	CcSEcCtD
Conivaptan—Anaemia—Dactinomycin—sarcoma	0.00274	0.00575	CcSEcCtD
Conivaptan—Mental disorder—Vincristine—sarcoma	0.00267	0.0056	CcSEcCtD
Conivaptan—Candida infection—Epirubicin—sarcoma	0.00263	0.00551	CcSEcCtD
Conivaptan—Erythema—Mitoxantrone—sarcoma	0.00258	0.00541	CcSEcCtD
Conivaptan—Hypertension—Thiotepa—sarcoma	0.00258	0.00541	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00253	0.0053	CcSEcCtD
Conivaptan—Confusional state—Thiotepa—sarcoma	0.00246	0.00516	CcSEcCtD
Conivaptan—Anaemia—Vincristine—sarcoma	0.00245	0.00514	CcSEcCtD
Conivaptan—Urinary tract disorder—Etoposide—sarcoma	0.00244	0.00511	CcSEcCtD
Conivaptan—Candida infection—Doxorubicin—sarcoma	0.00243	0.0051	CcSEcCtD
Conivaptan—Infection—Thiotepa—sarcoma	0.00242	0.00508	CcSEcCtD
Conivaptan—Urethral disorder—Etoposide—sarcoma	0.00242	0.00507	CcSEcCtD
Conivaptan—Infection—Dactinomycin—sarcoma	0.00241	0.00505	CcSEcCtD
Conivaptan—Nervous system disorder—Thiotepa—sarcoma	0.00239	0.00502	CcSEcCtD
Conivaptan—Sepsis—Epirubicin—sarcoma	0.00239	0.00501	CcSEcCtD
Conivaptan—Anaemia—Mitoxantrone—sarcoma	0.00239	0.005	CcSEcCtD
Conivaptan—Skin disorder—Thiotepa—sarcoma	0.00237	0.00497	CcSEcCtD
Conivaptan—Phlebitis—Epirubicin—sarcoma	0.00232	0.00487	CcSEcCtD
Conivaptan—Cardiac disorder—Etoposide—sarcoma	0.00229	0.0048	CcSEcCtD
Conivaptan—Hypertension—Vincristine—sarcoma	0.00229	0.0048	CcSEcCtD
Conivaptan—Angiopathy—Etoposide—sarcoma	0.00224	0.00469	CcSEcCtD
Conivaptan—Hypertension—Mitoxantrone—sarcoma	0.00223	0.00467	CcSEcCtD
Conivaptan—Mediastinal disorder—Etoposide—sarcoma	0.00222	0.00466	CcSEcCtD
Conivaptan—Sepsis—Doxorubicin—sarcoma	0.00221	0.00464	CcSEcCtD
Conivaptan—Infection—Vincristine—sarcoma	0.00215	0.00451	CcSEcCtD
Conivaptan—Phlebitis—Doxorubicin—sarcoma	0.00215	0.0045	CcSEcCtD
Conivaptan—Confusional state—Mitoxantrone—sarcoma	0.00212	0.00446	CcSEcCtD
Conivaptan—Nervous system disorder—Vincristine—sarcoma	0.00212	0.00445	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Thiotepa—sarcoma	0.00211	0.00442	CcSEcCtD
Conivaptan—Infection—Mitoxantrone—sarcoma	0.00209	0.00439	CcSEcCtD
Conivaptan—Pain—Thiotepa—sarcoma	0.00209	0.00438	CcSEcCtD
Conivaptan—Constipation—Thiotepa—sarcoma	0.00209	0.00438	CcSEcCtD
Conivaptan—Pain—Dactinomycin—sarcoma	0.00207	0.00434	CcSEcCtD
Conivaptan—Hypoglycaemia—Epirubicin—sarcoma	0.00205	0.0043	CcSEcCtD
Conivaptan—Cardiac failure—Epirubicin—sarcoma	0.00205	0.0043	CcSEcCtD
Conivaptan—Skin disorder—Mitoxantrone—sarcoma	0.00205	0.00429	CcSEcCtD
Conivaptan—Hypotension—Vincristine—sarcoma	0.00202	0.00424	CcSEcCtD
Conivaptan—Feeling abnormal—Thiotepa—sarcoma	0.00201	0.00422	CcSEcCtD
Conivaptan—Hyponatraemia—Epirubicin—sarcoma	0.00201	0.00421	CcSEcCtD
Conivaptan—Feeling abnormal—Dactinomycin—sarcoma	0.002	0.00418	CcSEcCtD
Conivaptan—Anaemia—Etoposide—sarcoma	0.00198	0.00416	CcSEcCtD
Conivaptan—Hypotension—Mitoxantrone—sarcoma	0.00197	0.00413	CcSEcCtD
Conivaptan—Insomnia—Vincristine—sarcoma	0.00196	0.0041	CcSEcCtD
Conivaptan—Body temperature increased—Thiotepa—sarcoma	0.00193	0.00404	CcSEcCtD
Conivaptan—Body temperature increased—Dactinomycin—sarcoma	0.00191	0.00401	CcSEcCtD
Conivaptan—Hypoglycaemia—Doxorubicin—sarcoma	0.0019	0.00397	CcSEcCtD
Conivaptan—Cardiac failure—Doxorubicin—sarcoma	0.0019	0.00397	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Vincristine—sarcoma	0.00187	0.00392	CcSEcCtD
Conivaptan—Dehydration—Epirubicin—sarcoma	0.00186	0.0039	CcSEcCtD
Conivaptan—Hyponatraemia—Doxorubicin—sarcoma	0.00186	0.00389	CcSEcCtD
Conivaptan—Hypertension—Etoposide—sarcoma	0.00185	0.00389	CcSEcCtD
Conivaptan—Constipation—Vincristine—sarcoma	0.00185	0.00388	CcSEcCtD
Conivaptan—Pain—Vincristine—sarcoma	0.00185	0.00388	CcSEcCtD
Conivaptan—Orthostatic hypotension—Epirubicin—sarcoma	0.00183	0.00383	CcSEcCtD
Conivaptan—Hypokalaemia—Epirubicin—sarcoma	0.00182	0.00381	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00182	0.00381	CcSEcCtD
Conivaptan—Pain—Mitoxantrone—sarcoma	0.0018	0.00378	CcSEcCtD
Conivaptan—Constipation—Mitoxantrone—sarcoma	0.0018	0.00378	CcSEcCtD
Conivaptan—Confusional state—Etoposide—sarcoma	0.00177	0.00371	CcSEcCtD
Conivaptan—Infection—Etoposide—sarcoma	0.00174	0.00365	CcSEcCtD
Conivaptan—Feeling abnormal—Mitoxantrone—sarcoma	0.00174	0.00364	CcSEcCtD
Conivaptan—Pruritus—Thiotepa—sarcoma	0.00173	0.00362	CcSEcCtD
Conivaptan—Dehydration—Doxorubicin—sarcoma	0.00172	0.00361	CcSEcCtD
Conivaptan—Body temperature increased—Vincristine—sarcoma	0.00171	0.00359	CcSEcCtD
Conivaptan—Skin disorder—Etoposide—sarcoma	0.0017	0.00357	CcSEcCtD
Conivaptan—Orthostatic hypotension—Doxorubicin—sarcoma	0.00169	0.00354	CcSEcCtD
Conivaptan—Hypokalaemia—Doxorubicin—sarcoma	0.00168	0.00353	CcSEcCtD
Conivaptan—Diarrhoea—Thiotepa—sarcoma	0.00167	0.0035	CcSEcCtD
Conivaptan—Body temperature increased—Mitoxantrone—sarcoma	0.00167	0.00349	CcSEcCtD
Conivaptan—Diarrhoea—Dactinomycin—sarcoma	0.00166	0.00347	CcSEcCtD
Conivaptan—Hypotension—Etoposide—sarcoma	0.00164	0.00343	CcSEcCtD
Conivaptan—Pollakiuria—Epirubicin—sarcoma	0.0016	0.00335	CcSEcCtD
Conivaptan—Hyperglycaemia—Epirubicin—sarcoma	0.00156	0.00327	CcSEcCtD
Conivaptan—Vomiting—Thiotepa—sarcoma	0.00155	0.00325	CcSEcCtD
Conivaptan—Pneumonia—Epirubicin—sarcoma	0.00155	0.00325	CcSEcCtD
Conivaptan—Infestation NOS—Epirubicin—sarcoma	0.00154	0.00323	CcSEcCtD
Conivaptan—Infestation—Epirubicin—sarcoma	0.00154	0.00323	CcSEcCtD
Conivaptan—Vomiting—Dactinomycin—sarcoma	0.00154	0.00323	CcSEcCtD
Conivaptan—Headache—Thiotepa—sarcoma	0.00153	0.00321	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Etoposide—sarcoma	0.00151	0.00317	CcSEcCtD
Conivaptan—Pain—Etoposide—sarcoma	0.0015	0.00314	CcSEcCtD
Conivaptan—Constipation—Etoposide—sarcoma	0.0015	0.00314	CcSEcCtD
Conivaptan—Urinary tract infection—Epirubicin—sarcoma	0.0015	0.00314	CcSEcCtD
Conivaptan—Diarrhoea—Vincristine—sarcoma	0.00148	0.0031	CcSEcCtD
Conivaptan—Pollakiuria—Doxorubicin—sarcoma	0.00148	0.0031	CcSEcCtD
Conivaptan—Haematuria—Epirubicin—sarcoma	0.00147	0.00308	CcSEcCtD
Conivaptan—Nausea—Thiotepa—sarcoma	0.00145	0.00304	CcSEcCtD
Conivaptan—Feeling abnormal—Etoposide—sarcoma	0.00144	0.00303	CcSEcCtD
Conivaptan—Hyperglycaemia—Doxorubicin—sarcoma	0.00144	0.00302	CcSEcCtD
Conivaptan—Diarrhoea—Mitoxantrone—sarcoma	0.00144	0.00302	CcSEcCtD
Conivaptan—Nausea—Dactinomycin—sarcoma	0.00144	0.00302	CcSEcCtD
Conivaptan—Pneumonia—Doxorubicin—sarcoma	0.00143	0.00301	CcSEcCtD
Conivaptan—Infestation—Doxorubicin—sarcoma	0.00143	0.00299	CcSEcCtD
Conivaptan—Infestation NOS—Doxorubicin—sarcoma	0.00143	0.00299	CcSEcCtD
Conivaptan—Body temperature increased—Etoposide—sarcoma	0.00139	0.00291	CcSEcCtD
Conivaptan—Urinary tract infection—Doxorubicin—sarcoma	0.00139	0.00291	CcSEcCtD
Conivaptan—Vomiting—Vincristine—sarcoma	0.00138	0.00288	CcSEcCtD
Conivaptan—Urinary tract disorder—Epirubicin—sarcoma	0.00137	0.00286	CcSEcCtD
Conivaptan—Oedema peripheral—Epirubicin—sarcoma	0.00136	0.00286	CcSEcCtD
Conivaptan—Haematuria—Doxorubicin—sarcoma	0.00136	0.00285	CcSEcCtD
Conivaptan—Urethral disorder—Epirubicin—sarcoma	0.00136	0.00284	CcSEcCtD
Conivaptan—Headache—Vincristine—sarcoma	0.00136	0.00284	CcSEcCtD
Conivaptan—Vomiting—Mitoxantrone—sarcoma	0.00134	0.00281	CcSEcCtD
Conivaptan—Headache—Mitoxantrone—sarcoma	0.00132	0.00277	CcSEcCtD
Conivaptan—Nausea—Vincristine—sarcoma	0.00129	0.0027	CcSEcCtD
Conivaptan—Cardiac disorder—Epirubicin—sarcoma	0.00128	0.00269	CcSEcCtD
Conivaptan—Urinary tract disorder—Doxorubicin—sarcoma	0.00126	0.00265	CcSEcCtD
Conivaptan—Oedema peripheral—Doxorubicin—sarcoma	0.00126	0.00264	CcSEcCtD
Conivaptan—Angiopathy—Epirubicin—sarcoma	0.00125	0.00263	CcSEcCtD
Conivaptan—Urethral disorder—Doxorubicin—sarcoma	0.00125	0.00263	CcSEcCtD
Conivaptan—Nausea—Mitoxantrone—sarcoma	0.00125	0.00262	CcSEcCtD
Conivaptan—Mediastinal disorder—Epirubicin—sarcoma	0.00125	0.00261	CcSEcCtD
Conivaptan—Pruritus—Etoposide—sarcoma	0.00124	0.0026	CcSEcCtD
Conivaptan—Mental disorder—Epirubicin—sarcoma	0.00121	0.00254	CcSEcCtD
Conivaptan—Erythema—Epirubicin—sarcoma	0.0012	0.00252	CcSEcCtD
Conivaptan—Malnutrition—Epirubicin—sarcoma	0.0012	0.00252	CcSEcCtD
Conivaptan—Diarrhoea—Etoposide—sarcoma	0.0012	0.00251	CcSEcCtD
Conivaptan—Cardiac disorder—Doxorubicin—sarcoma	0.00119	0.00249	CcSEcCtD
Conivaptan—Angiopathy—Doxorubicin—sarcoma	0.00116	0.00243	CcSEcCtD
Conivaptan—Mediastinal disorder—Doxorubicin—sarcoma	0.00115	0.00242	CcSEcCtD
Conivaptan—Mental disorder—Doxorubicin—sarcoma	0.00112	0.00235	CcSEcCtD
Conivaptan—Vomiting—Etoposide—sarcoma	0.00111	0.00234	CcSEcCtD
Conivaptan—Erythema—Doxorubicin—sarcoma	0.00111	0.00234	CcSEcCtD
Conivaptan—Malnutrition—Doxorubicin—sarcoma	0.00111	0.00234	CcSEcCtD
Conivaptan—Anaemia—Epirubicin—sarcoma	0.00111	0.00233	CcSEcCtD
Conivaptan—Headache—Etoposide—sarcoma	0.0011	0.0023	CcSEcCtD
Conivaptan—Nausea—Etoposide—sarcoma	0.00104	0.00218	CcSEcCtD
Conivaptan—Hypertension—Epirubicin—sarcoma	0.00104	0.00218	CcSEcCtD
Conivaptan—Anaemia—Doxorubicin—sarcoma	0.00103	0.00216	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.00102	0.00213	CcSEcCtD
Conivaptan—Dry mouth—Epirubicin—sarcoma	0.001	0.0021	CcSEcCtD
Conivaptan—Confusional state—Epirubicin—sarcoma	0.000991	0.00208	CcSEcCtD
Conivaptan—Infection—Epirubicin—sarcoma	0.000976	0.00205	CcSEcCtD
Conivaptan—Nervous system disorder—Epirubicin—sarcoma	0.000963	0.00202	CcSEcCtD
Conivaptan—Hypertension—Doxorubicin—sarcoma	0.000962	0.00202	CcSEcCtD
Conivaptan—Skin disorder—Epirubicin—sarcoma	0.000954	0.002	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000942	0.00197	CcSEcCtD
Conivaptan—Dry mouth—Doxorubicin—sarcoma	0.000927	0.00194	CcSEcCtD
Conivaptan—Hypotension—Epirubicin—sarcoma	0.000918	0.00193	CcSEcCtD
Conivaptan—Confusional state—Doxorubicin—sarcoma	0.000917	0.00192	CcSEcCtD
Conivaptan—Infection—Doxorubicin—sarcoma	0.000903	0.00189	CcSEcCtD
Conivaptan—Nervous system disorder—Doxorubicin—sarcoma	0.000892	0.00187	CcSEcCtD
Conivaptan—Insomnia—Epirubicin—sarcoma	0.000889	0.00186	CcSEcCtD
Conivaptan—Skin disorder—Doxorubicin—sarcoma	0.000883	0.00185	CcSEcCtD
Conivaptan—Hypotension—Doxorubicin—sarcoma	0.000849	0.00178	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Epirubicin—sarcoma	0.000848	0.00178	CcSEcCtD
Conivaptan—Constipation—Epirubicin—sarcoma	0.00084	0.00176	CcSEcCtD
Conivaptan—Pain—Epirubicin—sarcoma	0.00084	0.00176	CcSEcCtD
Conivaptan—Insomnia—Doxorubicin—sarcoma	0.000822	0.00172	CcSEcCtD
Conivaptan—Feeling abnormal—Epirubicin—sarcoma	0.00081	0.0017	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000785	0.00165	CcSEcCtD
Conivaptan—Pain—Doxorubicin—sarcoma	0.000777	0.00163	CcSEcCtD
Conivaptan—Constipation—Doxorubicin—sarcoma	0.000777	0.00163	CcSEcCtD
Conivaptan—Body temperature increased—Epirubicin—sarcoma	0.000777	0.00163	CcSEcCtD
Conivaptan—Feeling abnormal—Doxorubicin—sarcoma	0.000749	0.00157	CcSEcCtD
Conivaptan—Body temperature increased—Doxorubicin—sarcoma	0.000719	0.00151	CcSEcCtD
Conivaptan—Pruritus—Epirubicin—sarcoma	0.000695	0.00146	CcSEcCtD
Conivaptan—Diarrhoea—Epirubicin—sarcoma	0.000672	0.00141	CcSEcCtD
Conivaptan—Pruritus—Doxorubicin—sarcoma	0.000643	0.00135	CcSEcCtD
Conivaptan—Vomiting—Epirubicin—sarcoma	0.000625	0.00131	CcSEcCtD
Conivaptan—Diarrhoea—Doxorubicin—sarcoma	0.000622	0.0013	CcSEcCtD
Conivaptan—Headache—Epirubicin—sarcoma	0.000615	0.00129	CcSEcCtD
Conivaptan—Nausea—Epirubicin—sarcoma	0.000584	0.00122	CcSEcCtD
Conivaptan—Vomiting—Doxorubicin—sarcoma	0.000578	0.00121	CcSEcCtD
Conivaptan—Headache—Doxorubicin—sarcoma	0.000569	0.00119	CcSEcCtD
Conivaptan—Nausea—Doxorubicin—sarcoma	0.00054	0.00113	CcSEcCtD
